1. The Role of Angiopoietins in Neovascular Diabetes-Related Retinal Diseases

   • Juan David Collazos-Alemán
   • Sofía Gnecco-González
   • Carlos O. Mendivil

   Review Open access 04 November 2022 Pages: 1811 - 1821

   

2. Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating CTRP3 and PI3K/AKT Signaling

   • Yue Zhang
   • Guangning Xu
   • Renqun Ye

   Original Research Open access 14 September 2022 Pages: 1823 - 1834

   

3. Continuous Glucose Monitoring System Profile of Women with Gestational Diabetes Mellitus Missed Using Isolated Fasting Plasma Glucose-Based Strategies Alternative to WHO 2013 Criteria: A Cross-Sectional Study

   • Yashdeep Gupta
   • Charandeep Singh
   • Nikhil Tandon

   Original Research Open access 14 September 2022 Pages: 1835 - 1846

   

4. Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study

   • Mutsuko Minata
   • Kouji H. Harada
   • Hidemitsu Nakagawa

   Original Research Open access 22 September 2022 Pages: 1847 - 1860

   

5. Increased Healthcare Resource Use and Costs After Discontinuation of Liraglutide in Patients with Type 2 Diabetes from a Commercial- and Medicaid-Insured Claims Database

   • Chioma Uzoigwe
   • Josh Noone
   • Cory Gamble

   Original Research Open access 14 October 2022 Pages: 1861 - 1874

   

6. Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK

   • John J. Isitt
   • Stéphane Roze
   • Peter M. Lynch

   Original Research Open access 19 October 2022 Pages: 1875 - 1890

7. Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark

   • Reimar W. Thomsen
   • Lotte W. B. Christensen
   • Henrik T. Sørensen

   Original Research Open access 31 October 2022 Pages: 1891 - 1906

   

8. Impact of Diabetes on the Recurrence and Prognosis of Acute Kidney Injury in Older Male Patients: A 10-Year Retrospective Cohort Study

   • Xin Shen
   • Kunming Lv
   • Qingli Cheng

   Original Research Open access 31 August 2022 Pages: 1907 - 1920

   

9. Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study

   • Radhika Nair
   • Reema Mody
   • Todd Prewitt

   Original Research Open access 21 September 2022 Pages: 1921 - 1932

   

10. Cost-Effectiveness Analysis of Flash Glucose Monitoring System for People with Type 2 Diabetes Receiving Intensive Insulin Treatment

    • Ramzi Ajjan
    • S. Pinar Bilir
    • Diana Souto

    Original Research Open access 26 October 2022 Pages: 1933 - 1945

    

11. Initiation of the Fixed Combination IDegLira in Patients with Type 2 Diabetes on Prior Injectable Therapy: Insights from the EASY French Real-World Study

    • Blandine Tramunt
    • Emmanuel Disse
    • Pierre Gourdy

    Original Research Open access 04 November 2022 Pages: 1947 - 1963